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Background: Lower habitual physical activity and poor cardiorespiratory fitness are common
features of the metabolically abnormal obese (MAO) phenotype that contribute to increased
cardiovascular disease risk. The aims of the present study were to determine 1) whether
community-based exercise training transitions MAO adults to metabolically healthy, and
2) whether the odds of transition to metabolically healthy were larger for obese individuals who
performed higher volumes of exercise and/or experienced greater increases in fitness.
Methods and results: Metabolic syndrome components were measured in 332 adults
(190 women, 142 men) before and after a supervised 14-week community-based exercise program designed to reduce cardiometabolic risk factors. Obese (body mass index 30 kg ⋅ m2)
adults with two to four metabolic syndrome components were classified as MAO, whereas those
with no or one component were classified as metabolically healthy but obese (MHO). After
community exercise, 27/68 (40%) MAO individuals (P0.05) transitioned to metabolically
healthy, increasing the total number of MHO persons by 73% (from 37 to 64). Compared with
the lowest quartiles of relative energy expenditure and change in fitness, participants in the highest quartiles were 11.6 (95% confidence interval: 2.1–65.4; P0.05) and 7.5 (95% confidence
interval: 1.5–37.5; P0.05) times more likely to transition from MAO to MHO, respectively.
Conclusion: Community-based exercise transitions MAO adults to metabolically healthy.
MAO adults who engaged in higher volumes of exercise and experienced the greatest increase
in fitness were significantly more likely to become metabolically healthy. Community exercise
may be an effective model for primary prevention of cardiovascular disease.
Keywords: exercise, obesity, prevention, risk factors
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Despite current estimates indicating that ∼78 million US adults are obese, recent
epidemiological data from the National Health and Nutrition Examination Survey
(NHANES) suggest that a substantial portion of obese Americans are essentially
metabolically healthy.1 This subset of obese individuals, often referred to as metabolically healthy but obese (MHO),2 appear to be more resistant to the adverse cardiometabolic consequences that their metabolically abnormal obese (MAO) peers often
face.3,4 For example, recent findings from a large prospective study demonstrated
that the risks of all-cause and cardiovascular disease (CVD) mortality were 57% and
76% lower, respectively, in MHO compared with MAO adults.5 Although a universal
definition of the MHO phenotype has not been established, it has been argued that
the remarkable protection against CVD and diabetes observed in this population is
partly attributed to favorable metabolic profiles. Indeed, the MHO phenotype is most
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commonly characterized by preserved insulin sensitivity,
normal blood pressure, and an absence of dyslipidemia,
despite excess body fat.6–8 However, the precise physiological and/or lifestyle factors that contribute to the protective
metabolic characteristics in this subset of obese individuals
are not completely understood.
Regular physical activity9,10 and higher cardiorespiratory fitness11–13 alleviate the adverse impacts of obesity on
all-cause and CVD mortality through favorable modifications in cardiometabolic risk factors14,15 and reduced incidence of metabolic syndrome (MetS).16,17 It is not surprising
that greater habitual physical activity is thought to underlie
the favorable metabolic profiles of the MHO phenotype.
Indeed, both large-1 and small-scale18 observational studies indicate that physically active obese individuals more
often display healthy metabolic profiles than less active
obese individuals. In addition to greater physical activity,
more recently it has been demonstrated that higher cardiorespiratory fitness is an important underlying characteristic
that also confers protection against cardiometabolic risk in
MHO people.5,19 In a large cohort of the Aerobics Center
Longitudinal Study, Ortega et al5 reported that MHO adults
were significantly more fit than MAO adults. More importantly, when fitness was accounted for, the multivariate
adjusted hazard ratios of all-cause and CVD mortality and
incident nonfatal atherosclerotic CVD events in the MHO
cohort were similar to those of the normal-weight healthy
subjects. Although these findings highlight the protective
role of fitness with the MHO phenotype, they also present
the notion that exercise programs designed to increase
fitness may attenuate CVD risk in MAO persons. In fact,
it has been reported that after adjustment for fitness, the
risk of CVD mortality in MAO individuals was reduced
by 32%.5 This finding provides scientific support for a
beneficial effect of exercise in all subgroups of obesity
regardless of risk factor burden.
The distinguishing physical activity and fitness attributes
of the MHO phenotype prompt an intriguing question: can
an exercise intervention that augments cardiorespiratory
fitness transition MAO adults to metabolically healthy? We
have previously demonstrated that individuals performing
greater volumes of exercise as part of an evidence-based
community exercise program were more likely to eliminate
components of MetS.20 However, to date, no study has
investigated whether a community-based exercise intervention designed to increase exercise volume and fitness can
transition MAO adults to an MHO phenotype. Identifying
the therapeutic dose of exercise required to convert an MAO
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person to metabolically healthy would yield important
c linical information for the primary prevention of CVD in
obese individuals. Therefore, the primary purpose of the
present study was to determine 1) whether community-based
exercise training transitions MAO adults to metabolically
healthy, and 2) whether the odds of successful transition to
metabolically healthy are larger for obese individuals who
perform the highest volume of exercise and experience the
greatest increase in fitness.

Methods
Study population
A total of 332 healthy community members (190 women,
142 men; age range 28–88 years) included in the present
study enrolled in the exercise program between January 2007
and January 2012. All community members who participated
in the exercise program were Caucasian. Before participation, all of the participants had the research study and its
potential risks and benefits explained fully before providing
written informed consent. This study was approved by the
Institutional Review Board for the Protection of Human
Subjects at the University of Wisconsin-Eau Claire, Eau
Claire, WI, USA.

Pre-exercise health screening
and assessment of CVD risk factors
Upon enrolment in the exercise program, participants underwent a complete medical history and basic health assessment
of traditional CVD risk factors to determine whether it was
safe for them to engage in regular exercise. Information concerning the use of medications, lifestyle and physical activity
habits, and history or evidence of cardiovascular, pulmonary,
or metabolic disease were documented. Participants were
excluded from the study if they presented with a history of
cardiovascular, pulmonary, or metabolic disease. Select risk
factors (age, sex, total cholesterol, high-density lipoprotein
[HDL] cholesterol, smoking status, and systolic blood pressure) were applied to the 10-year Framingham Risk Score
algorithm to estimate future CVD risk before and after the
exercise program. All pre-exercise measurements were subsequently repeated after the 14-week exercise program.

Body composition and metabolic
measurements
Body mass was measured using a Detecto medical beam
balance (Cardinal Scale Manufacturing Co, Webb City, MO,
USA). Body mass index (BMI) was calculated as weight
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(kilograms) divided by height (meters) squared. Abdominal
obesity was estimated by minimal waist circumference measured at the smallest part of the abdomen at the highest part
of the iliac crest to the nearest 0.1 cm at the end of normal
expiration.21 Auscultatory resting systolic and diastolic blood
pressure were measured using a stethoscope and sphygmomanometer (Diagnostic 700 Series; American Diagnostic
Corporation, Hauppauge, NY, USA) following 5 minutes
of seated quiet rest using standard procedures.22 Resting
blood pressure measurements were performed twice on two
separate occasions separated by a minimum of 48 hours.
The mean of these two resting blood pressure measurements
was recorded.
Following an overnight fast, a small sample of blood
was taken from the index finger and analyzed for fasting
plasma lipids, lipoproteins, and glucose concentrations
using the Cholestech LDX System (Alere Inc., Waltham,
MA, USA) under strict standardized operating procedures.
Independent studies have provided data to indicate that the
Cholestech LDX system has excellent reproducibility with
standard clinical laboratory measurement of plasma lipids
and lipoproteins,23,24 and meets the National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III)
criteria for accuracy and reproducibility.25

Cardiorespiratory fitness
To estimate maximal cardiorespiratory fitness, we administered conventional submaximal exercise test protocols
(primarily walking or cycle ergometry protocols) using
standardized procedures appropriate for middle-aged to
older adults.26 Participants were instructed to refrain from
exercising 24 hours prior to their scheduled exercise test.
Submaximal exercise testing was completed in the morning
hours following a light breakfast with adequate hydration.
The submaximal test that was selected for participants was
based on their training goals and whether they presented
with musculoskeletal limitations that precluded the safe use
of a particular test. Each participant completed the same
submaximal exercise test at baseline and after the exercise
program.

Definition of the metabolically healthy
phenotypes
MHO individuals were identified if they presented with a
BMI 30 kg/m2 and had no or one component of MetS.
Our definition for MHO has been used elsewhere.4 MetS
was established according to NCEP ATP III criteria.27,28
The criteria include the following: 1) elevated triglycerides
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(150 mg/dL), 2) low HDL cholesterol (40 mg/dL in
men and 50 mg/dL in women), 3) elevated blood pressure
(systolic 130 mmHg and/or diastolic 85 mmHg), and
4) elevated fasting glucose (100 mg/dL). Abdominal obesity
(102 cm in men and 88 cm in women) was excluded, as
the purpose of the study was to evaluate changes in metabolic
health despite excess body fat. For example, a male subject
with the following metabolic profile was considered MHO:
triglycerides 140 mg/dL, HDL cholesterol 60 mg/dL, and
blood pressure 140/80 mmHg. Metabolically healthy nonobese
(MH-NO) participants were identified if they presented with a
BMI 30 kg/m2 and had no or one MetS component.

Definition of the metabolically abnormal
phenotypes
MAO individuals were identified if they presented with a
BMI 30 kg/m2 and had two to four components of MetS.
Similar to MHO, our definition for MAO has also been
applied previously in the literature.4 For example, a female
subject with the following metabolic profile would be considered MAO: triglycerides 170 mg/dL, HDL cholesterol
50 mg/dL, and blood pressure 150/90 mmHg. Metabolically
abnormal nonobese (MA-NO) participants were identified if
they had a BMI 30 kg/m2 and presented with two to four
components of MetS.

Evidence-based community exercise
programming
The community program provides an opportunity for members of the local community to participate in individualized
exercise for 14 weeks using established guidelines for exercise frequency, intensity, and duration, under the guidance
and supervision of qualified exercise professionals. A unique
feature of the community-based program, which utilizes
published data of randomized controlled clinical trials to
individualize exercise programming, is its evidence-based
practice approach. Specifically, the exercise prescription
was based on Studies of a Targeted Risk Reduction Intervention Through Defined Exercise (STRRIDE), which
demonstrated greater improvements in cardiovascular risk
factors with increasing doses of moderate-intensity exercise,
expressed as relative exercise energy expenditure (EE)
(14–23 kcal ⋅ kg-1 body weight per week).29 As such, each
participant was provided with an individualized weekly EE
goal of 14–23 kcal ⋅ kg-1 ⋅ week-1. The EE goal was used to
calculate a minimum weekly exercise duration necessary to
reduce CVD risk (corresponding to 40%–60% target VO2
reserve) using the following calculation:
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Minimum minutes of exercise per week
= [14 kcal ⋅ kg-1 ⋅ week-1 × participant body mass]
÷ [(40% target VO2 reserve work load × participant
   body mass) ÷ 1,000 × 5 kcal L ⋅ O2-1].

Exercise volume (minutes/week) was then divided by
the target frequency goal for each participant to obtain daily
exercise duration. The maximum minutes of exercise per
week, reflected by 60% VO2 reserve and 23 ⋅ kcal kg-1 ⋅ week-1,
was also determined. Each member consulted with a team
of exercise professionals and was assigned a University of
Wisconsin-Eau Claire Department of Kinesiology senior
student, who served as their exercise trainer. The trainers
worked directly under the supervision of qualified PhDtrained exercise physiologists. Members engaged in their
morning exercise 3 days per week between 5.30 am and 8 am
for 14 weeks via brisk walking, water aerobics, stationary
cycling, or crosstraining. At the beginning of each exercise
session, trainers met with their respective community member to go over the morning exercise activities. The trainers
coached members during their exercise sessions, provided
motivational support, engaged in spotting, and corrected
exercise technique. The student trainers also adjusted exercise
intensities, modes, and durations with consultation from the
exercise physiologists. Exercise progression and adherence
were tracked by the use of daily exercise logs. In addition
to tracking exercise frequency, intensity, and duration, the
logs documented resting and exercise heart rate, ratings of
perceived exertion, exercise time, metabolic equivalents, EE,
target intensities, exercise modes, as well as the repetitions,
sets, and exercises of their respective strength training routine.
Log data were stored and saved in a FileMaker Pro database
software program (FileMaker Pro, Santa Claire, CA).

Statistical analysis
All analyses were performed using Statistical Package
for the Social Sciences, Version 19.0 (IBM Corporation,
Armonk, NY, USA). All variables were initially checked
for normality. Measures of centrality and spread are presented as frequency and mean ± standard deviation. Mean
differences in all outcome variables between baseline and
postprogram were assessed using paired t-tests. Mean differences in the transition from MAO to MHO were assessed
using independent t-tests. The number of individual MetS
components and the categorization of MHO or MAO
were according to the NCEP ATP III guidelines.27 Chisquare tests were used to analyze the point prevalence of
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metabolically abnormal individuals (ie, MAO and MA-NO)
who successfully transitioned to metabolically healthy (ie,
MHO and MH-NO) between baseline and postprogram.
Dichotomous variables were created to define those individuals who successfully transitioned from MAO to MHO (or
from MA-NO to MH-NO) compared with those individuals
who experienced no phenotype transition: 0= no transition
from MAO to MHO; 1= positive transition from MAO to
MHO. Low cardiorespiratory fitness was also identified as
a risk factor.30 Individuals in the lowest 25th percentile rank
according to age and sex were categorized as unfit.26 The
same coding scheme used for the transition between MAO
to MHO was also applied to changes in cardiorespiratory
fitness status. Logistic regression was then performed to
model the odds (±95% confidence interval [CI]) of transition between phenotype on relative EE status (inserted into
the model as a categorical variable according to relative EE
quartiles), adjusting for age and sex. Logistic regression was
also used to model the percentage fitness change status and
was inserted into the model as percentage fitness change
quartiles. The level of statistical significance was set at
P0.05 for all analyses.

Results
All subjects completed the 14-week exercise program
without incident, although, as expected, there was variability in the volume of exercise among participants. The
mean exercise intensity for the total cohort was 42% VO2
reserve, with no differences between the obese or nonobese
phenotypes. Baseline point prevalence of obese persons in
the community exercise cohort was 31% (104/332). Of these,
∼65% (n=68) were identified as MAO and 35% (n=37) were
identified as MHO.

Community exercise and obese
phenotypes
Community exercise favorably impacted cardiometabolic
risk factors in the obese cohort, irrespective of phenotype
(Tables 1 and 2). Importantly, however, a significant portion of MAO adults successfully transitioned to an MHO
phenotype after community exercise. As a result, the point
prevalence of MAO adults dropped significantly (P0.05)
after exercise training as 40% (n=27) transitioned to
metabolically healthy, increasing the total number of MHO
persons by 73% (from 37 to 64). Table 1 presents baseline
and postprogram health outcomes for the MAO subjects
who successfully transitioned to metabolically healthy.
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Table 1 Baseline and postprogram characteristics of the MAO and MA-NO phenotype groups who transitioned to metabolically
healthy (values are mean ± standard deviation)
Outcome variable

MAO to MHO
(n=27)

Absolute EE (kcal ⋅ wk-1)
Relative EE (kcal ⋅ kg-1 ⋅ wk-1)
Waist circumference (cm)
Body mass index (kg/m2)
Body mass (kg)
Systolic BP (mmHg)
Diastolic BP (mmHg)
Total cholesterol (mmol ⋅ L-1)
HDL cholesterol (mmol ⋅ L-1)
LDL cholesterol (mmol ⋅ L-1)
Triglycerides (mmol ⋅ L-1)
Glucose (mmol ⋅ L-1)
CR fitness (mL ⋅ kg-1 ⋅ min-1)
10-year risk score (%)

MA-NO to MH-NO
(n=15)

Baseline

Postprogram

Baseline

Postprogram

371±512
3.7±5.0
112.0±13.0
34.1±3.8
101.9±17.9
126±11
78±7
4.8±1.2
1.0±0.3
2.8±1.0
2.0±0.9
5.9±0.9
28.4±7.8
5.5±5.5

1,770±552*
17.9±5.5*
109.3±12.5*
34.0±3.7
101.4±17.5
120±9*
76±7*
4.8±1.1
1.1±0.3*
2.7±0.9
1.7±0.8*
5.4±0.6*
32.0±8.6*
5.1±5.2

643±549
8.6±7.6
89.2±6.9
25.4±3.1
75.3±8.0
122±11
75±9
4.7±1.3
1.0±0.2
3.1±1.1
1.5±0.7
6.3±0.8
32.2±5.5
5.1±7.0

1,425±315*
19.4±5.2*
88.0±7.1
25.3±3.2
74.8±8.0
119±8
75±7
4.6±1.1
1.1±0.3*
3.0±0.9
1.4±0.4
5.5±0.5*
36.6±6.8*
4.7±6.9*

Note: *P,0.05 for within-group change versus baseline by paired t-test.
Abbreviations: BP, blood pressure; CR, cardiorespiratory; EE, energy expenditure; HDL, high-density lipoprotein; LDL, low-density lipoprotein; MA-NO, metabolically
abnormal nonobese; MAO, metabolically abnormal obese; MH-NO, metabolically healthy nonobese; MHO, metabolically healthy obese.

Table 2 Baseline and postprogram characteristics of the obese and nonobese phenotypes who did not transition (values are mean ±
standard deviation)
Outcome variable

Obese (no transition)
MHO
n=37
Baseline

Absolute EE
(kcal ⋅ wk-1)
Relative EE
(kcal ⋅ kg-1 ⋅ wk-1)
Waist circumference
(cm)
Body mass index
(kg/m2)
Body mass (kg)
Systolic BP (mmHg)
Diastolic BP (mmHg)
Total cholesterol
(mmol ⋅ L-1)
HDL cholesterol
(mmol ⋅ L-1)
LDL cholesterol
(mmol ⋅ L-1)
Triglycerides
(mmol ⋅ L-1)
Glucose (mmol ⋅ L-1)
CR fitness
(mL ⋅ kg-1 ⋅ min-1)
10-year risk score (%)

Nonobese (no transition)
MAO
n=41

Postprogram

Baseline

MH-NO
n=200

MA-NO
n=9

Postprogram

Baseline

Postprogram

Baseline

Postprogram

438±512

1,422±381*

438±519

1,927±615*

492±488

1,371±483*

661±475

1,045±164

4.8±5.4

15.8±3.8*

4.2±5.2

17.7±5.2*

6.2±6.3

17.1±6.2*

8.5±5.9

13.4±1.7

102.3±12.2

100.1±12.5*

118.2±13.7

116.6±13.6*

92.6±19.0

91.6±18.2*

90.4±7.4

89.2±8.0*

34.5±3.4

34.2±3.4*

35.1±4.0

34.9±4.0

26.7±1.9

26.6±1.9*

26.1±3.4

25.8±3.2

91.7±16.4
120±10
76±7
5.0±1.1

90.7±15.8*
118±7*
73±7
4.9±0.9

110.7±17.5
131±13
80±9
4.8±1.2

110.1±17.7
125±11*
76±0.9*
4.6±0.2*

82.8±19.9
118±10
74±8
4.8±1.0

82.3±19.8*
116±10*
73±7
4.8±1.0

79.1±8.6
128±17
81±14
4.7±1.7

78.3±8.5
120±19*
76±14*
4.6±1.5

1.3±0.4

1.4±0.3*

0.8±0.3

0.9±0.8*

1.4±0.4

1.5±14*

0.9±0.4

1.0±0.3

3.0±1.0

2.9±0.8*

2.9±0.9

2.9±0.8

2.9±0.9

2.8±0.9*

3.5±1.4

3.3±1.3

1.4±0.7

1.3±0.6

2.4±1.1

2.0±0.8*

1.1±0.5

1.1±0.4

2.3±0.7

2.2±0.6

5.8±0.9
25.1±7.0

5.6±0.8*
27.6±7.6*

6.7±1.4
29.0±8.7

6.3±1.2*
32.2±9.0*

5.4±1.1
33.1±8.4

5.3±0.9*
36.1±8.8*

6.3±0.9
29.5±8.0

5.8±0.6
31.8±7.0

1.5±2.6

1.5±2.3

6.7±6.4

6.1±5.4

5.4±6.3

4.7±5.5*

5.4±4.3

4.6±3.7*

Note: *P,0.05 for within-group change versus baseline by paired t-test.
Abbreviations: BP, blood pressure; CR, cardiorespiratory; EE, energy expenditure; HDL, high-density lipoprotein; LDL, low-density lipoprotein; MA-NO, metabolically
abnormal nonobese; MAO, metabolically abnormal obese; MH-NO, metabolically healthy nonobese; MHO, metabolically healthy obese.
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Paired t-tests revealed significant mean differences (P0.05)
for all health outcomes, with the exception (P0.05) of
BMI, body mass, total cholesterol, LDL cholesterol, and
10-year risk score. As shown in Figure 1A, the number of
MAO people identified with low HDL cholesterol, elevated
triglycerides, and impaired fasting glucose was reduced
50%–74% postprogram. Impaired fasting blood glucose
(n=14) was the most common MetS component eliminated.
As a result of the successful transition in the MAO group, the
point prevalence of MHO persons in the entire community
cohort significantly increased (P0.05) from 11% to 19%
after the exercise program.
The odds of phenotype transition across quartiles of
relative EE and percentage change in cardiorespiratory
fitness are shown in Figure 2. Logistic regression showed
that compared with the lowest quartile (Q1) of relative EE,
participants in the highest quartile (Q4) were 11.6 (95% CI
2.1–65.4; P0.05) times more likely to transition from MAO
to MHO (Figure 2 top panel). Similarly, logistic regression
showed that compared with the lowest quartile (Q1) of percentage change in cardiorespiratory fitness, participants in the
highest quartile (Q4) were 7.5 (95% CI 1.5–37.5; P0.05)
times more likely to transition from MAO to MHO (Figure 2
bottom panel).
Although a considerable portion of MAO people transitioned to a healthy obese phenotype, a number of MAO
individuals (n=41) did not. Baseline and postprogram health
outcomes for MAO individuals who did not transition are presented in Table 2. Similar to the MAO adults who transitioned
to metabolically healthy (Table 1), MAO individuals who
did not transition demonstrated significant mean reductions
in all health outcomes after community exercise, with the
exception of BMI, body mass, and LDL cholesterol (Table 2).

Metabolic syndrome risk factors

A

40

Nevertheless, as shown in Figure 3A, there was no significant
change in the point prevalence of MetS components after
community exercise in this MAO subgroup.
All 36 of the MHO individuals identified at baseline
remained metabolically healthy postprogram. Interestingly,
although their baseline metabolic profiles were favorable
as expected, community exercise participation still elicited
significant improvements in all health outcomes, with the
exception of diastolic blood pressure, total cholesterol, and
triglycerides. In fact, as illustrated in Figure 3B, the number
of MHO people who demonstrated one MetS risk factor at
baseline was significantly reduced after community exercise.
In particular, the number of MHO people with baseline
elevated triglycerides (n=13) and impaired fasting glucose
(n=21) was significantly reduced by 30% and 24% after
the exercise program, respectively (Figure 3B; P0.05).

Community exercise and nonobese
phenotypes
Baseline point prevalence of nonobese persons in the community exercise cohort was 67% (224/332). Within the nonobese
group, ∼11% (n=24) were identified as MA-NO and 89%
(n=200) were identified as MH-NO. Similar to the favorable
effects of community exercise on metabolic profiles in the
obese phenotype groups, several (n=15) MA-NO participants
successfully transitioned to an MH-NO phenotype after community exercise. Indeed, paired t-tests revealed a significant
decrease in 10-year CVD risk score, which was reflected by
marked improvements in HDL cholesterol, cardiorespiratory fitness, and blood glucose concentrations (Table 1).
Figure 1B shows the point prevalence of MetS components
before and after community exercise in the MA-NO individuals who transitioned to metabolically healthy. The number
B

Before community exercise

40

After community exercise
30

30

20

*

*

*
20

10

*

*

10

*
0

Elevated
blood pressure

Low
HDL-cholesterol

Elevated
triglycerides

Impaired
fasting glucose

0

Elevated
blood pressure

Low
HDL-cholesterol

Elevated
triglycerides

Impaired
fasting glucose

Figure 1 Changes in point prevalence of metabolic syndrome risk factors before and after community exercise in the metabolically abnormal obese participants who
transitioned to a metabolically healthy obese phenotype (A), and metabolically abnormal nonobese participants who transitioned to a metabolically healthy nonobese
phenotype (B).
Notes: *P,0.05 versus before community exercise. Data analyzed using Crosstabs Procedure, Chi-square difference testing.
Abbreviations: HDL, high-density lipoprotein; LDL, low-density lipoprotein.
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Figure 2 The odds of transition from the metabolically abnormal obese (MAO) phenotype to the metabolically healthy obese (MHO) phenotype across quartiles of increased
relative energy expenditure (top panel) and increased cardiorespiratory fitness (bottom panel) adjusted for age and sex.
Note: Values represent odds ratios ±95% confidence interval.
Abbreviation: VO2 max, maximal oxygen uptake.

of MA-NO people identified with elevated blood pressure,
low HDL cholesterol, and impaired fasting glucose was
significantly reduced postcommunity exercise. Impaired
fasting blood glucose (n=11) was the most common MetS
risk factor eliminated (Figure 1B). Given these beneficial
phenotypic changes, the point prevalence of MA-NO adults

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014:7

in the entire community cohort dropped significantly (from
7.2% to 4.5%; P0.05) postprogram as ∼63% (15/24) transitioned to metabolically healthy.
Baseline and postprogram health outcomes for the
MA-NO individuals (n=9) who did not transition are presented in Table 2. MA-NO individuals who did not transition
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Figure 3 Changes in point prevalence of metabolic syndrome risk factors before and after community exercise in the metabolically abnormal obese (A), metabolically healthy
obese (B), metabolically abnormal nonobese (C), and metabolically healthy nonobese (D) subgroups who did not transition.
Notes: *P0.05 versus before community exercise. Data analyzed using Crosstabs Procedure, Chi-square difference testing.
Abbreviations: HDL, high-density lipoprotein; LDL, low-density lipoprotein.

demonstrated significant mean reductions in waist circumference, blood pressure, and 10-year risk score postprogram.
Aside from these favorable changes, there was no significant
decrease in the point prevalence of MetS components after
community exercise (Figure 3C).
All 200 of the MH-NO individuals identif ied at
baseline remained metabolically healthy postprogram
(Table 2). Community exercise elicited significant, albeit modest, improvements in all health outcomes, with the exception
of diastolic blood pressure, total cholesterol, and triglycerides.
The point prevalence of MH-NO people with low HDL cholesterol at baseline significantly decreased after community exercise (from 28 to 19; P0.05, Figure 3D). Likewise, the point
prevalence of MH-NO people with impaired fasting glucose
at baseline was also reduced (from 58 to 39; P0.05).

Discussion
The primary finding of the present study is that a shortterm community exercise intervention positively transitions
individuals across the phenotypic spectrum from MAO
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to MHO, in part by eliminating components of MetS and
increasing cardiorespiratory fitness. Indeed, the number of
people identified with MAO was reduced by 40% following
supervised community exercise, a finding that is supported
by the 73% increase in the total number of MHO persons
at program conclusion. Moreover, our findings suggest
that higher volumes of exercise (expressed as relative EE)
can substantially increase the likelihood that a person will
transition from an MAO to an MHO phenotype. Although
regular physical activity is thought to underpin the favorable
metabolic profiles of the MHO phenotype, to our knowledge
the impact of a community-wide physical activity intervention to transition individuals from MAO to MHO has not
been scientifically explored. As such, the results of this novel
study are encouraging and support the tremendous potential
to implement evidence-based exercise programming into
the community to prevent obesity-related MetS, CVD, and
mortality from CVD.
Current data exhibit that approximately 35% of American
adults are obese.31 From a public health standpoint, it has
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been well established that obese adults are at increased risk
for developing type 2 diabetes, acute thrombotic events, such
as myocardial infarction and stroke, and premature mortality when compared with their nonobese counterparts.32,33
However, recent evidence has focused on the unique MHO
phenotype subgroup of obese individuals who possess normal metabolic features despite increased adiposity, and who
exhibit similar risk of mortality from all-cause and CVD to
metabolically healthy normal-weight individuals.4 Previously,
it has been reported from prospective cohort studies and
observational epidemiological data that physical activity
is a common attribute differentiating between the MHO
and MAO phenotypes.1,18 The most striking finding of our
study is that MAO adults who engaged in higher volumes of
exercise were significantly more likely to become metabolically healthy. To our knowledge, we are the first to show that
metabolic phenotype can be successfully transitioned through
participation in a supervised community evidence-based
exercise program. The fact that baseline MAO individuals
who performed the highest volume of relative EE (ie, 22.4
kcal ⋅ kg-1 body weight per week) were nearly 12 times more
likely to transition to the MHO phenotype represents an
important clinical finding. Indeed, identification of the efficacious therapeutic dosage of exercise required to positively
manage the MAO phenotype holds important implications
for targeted preventive strategies. To this aim, our current
findings provide important preliminary experimental exercise
prescription data.
Although not included in the NCEP ATP III criteria for
MetS, low cardiorespiratory fitness has been identified as a
feature of the MetS17 and MAO phenotype.5 Moreover, in the
past decade, being unfit has garnered considerable attention
as an independent and powerful predictor of CVD risk and
premature mortality. For example, Williams30 showed in a
meta-analysis that there was a precipitous increase in relative
risk for CVD in the lowest quartile of cardiorespiratory fitness.
More recently Blair34 estimated that low cardiorespiratory
fitness accounted for more overall deaths when compared
with deaths that could be attributed to traditional CVD risk
factors, such as obesity, smoking, hypertension, high cholesterol, and diabetes. In the present study, MAO adults who
demonstrated the greatest improvements in cardiorespiratory
fitness (ie, 20%) were significantly more likely to become
metabolically healthy (Figure 2). Overall, cardiorespiratory
fitness was improved, on average, more than one metabolic
equivalent (1 MET =3.5 mL/kg/min) in the MAO to MHO
phenotypic transition group following supervised community
exercise. This improvement likely has important long-term
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p revention implications, as a recent study reported that a one
MET increase in cardiorespiratory fitness was associated with
an 18% reduction in deaths due to CVD.35
Well-designed studies examining the impact of community-wide physical activity initiatives focusing on primary
prevention of CVD in large groups of people, particularly
people stratified to low or moderate risk, are limited.
However, it appears that renewed focus at the community and
population levels aimed at increasing healthy behaviors and
physical activity to eliminate cardiometabolic risk factors and
positively transition individuals across the phenotypic spectrum should be a primary national public health concern.36
Certainly, modest reductions in cardiometabolic risk factors
that occur as a result of community initiatives will have large
benefits in CVD prevention at the population level.37–39 For
example, it has been demonstrated that a 1-year randomized
study showing that a multiple risk factor community-based
intervention trial (ie, risk factor reduction mediated by CVD
counseling and physical activity opportunities on a community
level) reduced 10-year coronary heart disease risk by ∼26%
in high-risk black families compared with ∼3% with standard
primary care.40 The significant reduction in risk was attributed, in part, to favorable modifications of MetS components.
Indeed, ∼60% of subjects randomized to the community
intervention eliminated high blood pressure as a risk factor
and ∼50% eliminated high LDL cholesterol. Furthermore,
we have previously reported that a community exercise program is an effective method to reduce cardiovascular risk in
adults by substantially decreasing the prevalence of MetS and
elimination of individual MetS components, most notably
low HDL cholesterol and impaired fasting blood glucose.20
These previous findings and results from the present study
provide experimental support to implement community-wide
primary prevention initiatives focusing on increasing physical
activity to significantly reduce the burden of obesity and its
associated comorbidities in the community.
It is well established that exercise-only interventions
elicit modest weight loss reductions.41 Our findings across all
phenotype groups corroborate these previous assessments.
Comparatively, we did observe significant waist circumference reductions in those individuals who transitioned from
the MAO to the MHO phenotype. This observation has
previously been reported elsewhere in the literature42 and
mechanistically is of clinical significance, as abdominal
obesity contributes to insulin resistance and a constellation
of associated coronary heart disease risk factors, including
dyslipidemia, elevated blood pressure, impaired fibrinolysis, and chronic inflammation.31,43 High lipolytic rates are
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commonly linked with abdominal obesity and subsequent
impaired fatty acid oxidation.44 Moreover, a mismatch
between free fatty acid uptake and oxidation has been shown
to activate proinflammatory pathways within skeletal muscle
that impair insulin action.45 In sum, decreased abdominal
obesity coupled with lowered inflammation and improved
insulin sensitivity are likely important mediating factors for
transitioning individuals across the phenotypic spectrum
from MAO to MHO.

program been extended. In particular, a longer exercise
intervention may hold important clinical value for the 60%
of MAO individuals in the present study who failed to transition to the MHO phenotype over the course of the exercise
program. For example, the fact that the “no transition” MAO
phenotype exhibited a significantly more severe risk factor
profile at baseline is suggestive for the requirement of a
longer exercise intervention.

Study limitations and strengths

In conclusion, these findings indicate that supervised community exercise can transition MAO adults to an MHO
phenotype. MAO adults who engaged in higher volumes of
exercise and those who demonstrated greater improvements
in fitness were significantly more likely to become metabolically healthy. Importantly, the unfavorable metabolic
characteristics of obesity are not irreversible. Community
exercise should be considered an effective model for the
primary prevention of CVD in MAO adults. These results
suggest that a community-based physical activity intervention represents an enormous opportunity to reduce CVD
risk and should be considered an effective model of primary
prevention. Certainly, translating scientific evidence into
action at the community level may help to restore enthusiasm
for primary prevention on a national scale.

There are a number of experimental considerations regarding the present study. First, as with all retrospective studies, we cannot rule out the possibility that other factors
(eg, medication use and lifestyle, dietary, and behavior
changes) contributed to MAO to MHO phenotype transition, irrespective of the community exercise program.
However, in an effort to minimize the influence of potential confounding lifestyle and pharmacological factors,
we carefully included participants who were nonsmokers
and free of overt cardiovascular and metabolic disease, as
assessed by medical history. Our findings therefore should
be viewed in the context of the sample population studied.
Second, although the primary focus of the present study
was on the effectiveness of community-based exercise
training for transitioning MAO adults to an MHO phenotype, another important observation we encountered was
the significant number of nonobese metabolically abnormal
individuals who successfully transitioned to nonobese
metabolically healthy. This phenotype transition likely
has important primary prevention implications that merit
further attention.
A major strength of the present study was the evidencebased exercise program, which was modeled from published data of randomized controlled trials that identified
the optimal dose (ie, kcal ⋅ kg-1 body weight per week) and
intensity (40%–60% VO2 reserve) of exercise to eliminate
MetS components and thus elicit successful MAO to MHO
phenotype transition in asymptomatic adults. In addition,
the exercise program was personalized and carefully considered each participant’s goals, physical limitations, and risk
factors. We provided professional guidance and supervision,
and periodically reviewed the program to ensure that it was
meeting their health needs. Lastly, although the effectiveness
of the exercise program to transition a significant number
of MAO individuals to the MHO phenotype in a relatively
short period of time (14 weeks) is a strength, perhaps even
more individuals would have transitioned had the exercise
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